Business Description
AbbVie Inc
NAICS : 325412
SIC : 5122
ISIN : US00287Y1091
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 5.73 | |||||
Debt-to-EBITDA | 3.46 | |||||
Interest Coverage | 6.09 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.07 | |||||
Beneish M-Score | -2.87 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.8 | |||||
3-Year EBITDA Growth Rate | 9.6 | |||||
3-Year EPS without NRI Growth Rate | 49.1 | |||||
3-Year FCF Growth Rate | 7.4 | |||||
3-Year Book Growth Rate | -7.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 32.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 1.15 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.59 | |||||
9-Day RSI | 46.59 | |||||
14-Day RSI | 53.32 | |||||
6-1 Month Momentum % | 16.12 | |||||
12-1 Month Momentum % | 14.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.87 | |||||
Quick Ratio | 0.76 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 69.9 | |||||
Days Sales Outstanding | 76.32 | |||||
Days Payable | 59.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.36 | |||||
Dividend Payout Ratio | 0.67 | |||||
3-Year Dividend Growth Rate | 7.8 | |||||
Forward Dividend Yield % | 3.48 | |||||
5-Year Yield-on-Cost % | 5.42 | |||||
Shareholder Yield % | 6.87 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.42 | |||||
Operating Margin % | 24.92 | |||||
Net Margin % | 8.95 | |||||
FCF Margin % | 40.62 | |||||
ROE % | 36.93 | |||||
ROA % | 3.58 | |||||
ROIC % | 9.52 | |||||
ROC (Joel Greenblatt) % | 171.32 | |||||
ROCE % | 8.18 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 64.28 | |||||
Forward PE Ratio | 15.97 | |||||
PE Ratio without NRI | 19.8 | |||||
Shiller PE Ratio | 39.39 | |||||
Price-to-Owner-Earnings | 24.49 | |||||
PEG Ratio | 1.28 | |||||
PS Ratio | 5.73 | |||||
PB Ratio | 29.91 | |||||
Price-to-Free-Cash-Flow | 14.1 | |||||
Price-to-Operating-Cash-Flow | 13.62 | |||||
EV-to-EBIT | 42.71 | |||||
EV-to-Forward-EBIT | 14.25 | |||||
EV-to-EBITDA | 21.07 | |||||
EV-to-Forward-EBITDA | 13.8 | |||||
EV-to-Revenue | 6.66 | |||||
EV-to-Forward-Revenue | 6.64 | |||||
EV-to-FCF | 16.35 | |||||
Price-to-Projected-FCF | 1.47 | |||||
Price-to-DCF (Earnings Based) | 0.9 | |||||
Price-to-DCF (FCF Based) | 0.47 | |||||
Price-to-Median-PS-Value | 1.31 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.96 | |||||
Earnings Yield (Greenblatt) % | 2.34 | |||||
FCF Yield % | 7 | |||||
Forward Rate of Return (Yacktman) % | 26.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AbbVie Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 54,318 | ||
EPS (TTM) ($) | 2.73 | ||
Beta | 0.59 | ||
Volatility % | 23.05 | ||
14-Day RSI | 53.32 | ||
14-Day ATR ($) | 2.97323 | ||
20-Day SMA ($) | 178.81 | ||
12-1 Month Momentum % | 14.54 | ||
52-Week Range ($) | 92.98 - 182.72 | ||
Shares Outstanding (Mil) | 1,766.47 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AbbVie Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AbbVie Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
AbbVie Inc Frequently Asked Questions
What is AbbVie Inc(LTS:0QCV)'s stock price today?
When is next earnings date of AbbVie Inc(LTS:0QCV)?
Does AbbVie Inc(LTS:0QCV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |